Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Oct;70(10):1237-42.
doi: 10.1007/s00228-014-1722-x. Epub 2014 Jul 29.

Consequences of dextropropoxyphene market withdrawal in elderly patients with chronic pain

Affiliations
Multicenter Study

Consequences of dextropropoxyphene market withdrawal in elderly patients with chronic pain

Laurent Becquemont et al. Eur J Clin Pharmacol. 2014 Oct.

Abstract

Objective: Describe the consequences of dextropropoxyphene (DXP) market withdrawal on analgesic prescriptions and on the quality of therapeutic management of chronic pain.

Patients and methods: From a cohort of non-institutionalised elderly patients with chronic pain recruited by general practitioners, we selected patients who were treated with DXP daily for at least 6 months just prior to DXP market withdrawal and who had an evaluation of pain and its impact on daily activities before and after DXP withdrawal.

Results: One hundred three patients took DXP daily for chronic pain. Immediately after DXP market withdrawal, 42 (40.8%), 55 (53.4%) and 3 (2.9%) patients were treated with step 1, 2 and 3 analgesics, respectively, and 3 patients (2.9%) were no longer receiving any analgesic medication. Among the 55 patients who continued on step 2 analgesics, 37 were treated with tramadol, 14 with codeine and 9 with opium. Pain intensity and the impact of pain on daily activities remained stable.

Conclusion: DXP market withdrawal had no consequences on the intensity or impact of chronic pain in elderly patients.

PubMed Disclaimer

References

    1. PLoS Med. 2012;9(5):e1001213 - PubMed
    1. JAMA. 1963 Sep 21;185:914-9 - PubMed
    1. Therapie. 2011 Jan-Feb;66(1):25-8 - PubMed
    1. Fundam Clin Pharmacol. 2009 Apr;23(2):247-52 - PubMed
    1. BMC Clin Pharmacol. 2010 Mar 18;10:6 - PubMed

Publication types

LinkOut - more resources